TETRAPHASE PHARMACEUTICALS INC Accounts Payable
TETRAPHASE PHARMACEUTICALS INC had Accounts Payable of $1.98 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2020-05-07
- 2020-03-31: Accounts Payable, Current $1.98M.
- 2019-12-31: Accounts Payable, Current $2.43M.
- 2019-09-30: Accounts Payable, Current $1.75M.
- 2019-06-30: Accounts Payable, Current $2.08M.
| Period end | Accounts Payable, Current |
|---|---|
| 2020-03-31 | $1.98M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.43M 10-Q · filed 2020-05-07 |
| 2019-09-30 | $1.75M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.08M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.69M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.21M 10-K · filed 2020-03-12 |
| 2018-09-30 | $5.20M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $2.12M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $3.60M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $5.31M 10-K · filed 2019-03-15 |
| 2017-09-30 | $8.89M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $6.92M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $3.60M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $2.56M 10-K · filed 2018-03-06 |
| 2016-09-30 | $3.62M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $2.54M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.49M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.86M 10-K · filed 2017-03-13 |
| 2015-09-30 | $1.74M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $5.79M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $5.59M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $4.11M 10-K · filed 2016-02-25 |
| 2014-09-30 | $3.74M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $6.72M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $3.92M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.88M 10-K · filed 2015-03-06 |
| 2013-09-30 | $2.92M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.96M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $2.03M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $2.02M 10-K · filed 2014-03-06 |